top of page

PROGRAMME Postgraduate Course

Where basic scientists meet clinicians:

Novel insights in microbiota interactions and their clinical utility

Course directors: Annemieke Smet, Benedicte De Winter, Sarah Lebeer,

Nele Brusselaers, Marie Joossens, Lukas Van Oudenhove

Thursday, September 7, 2023
Room Gorilla 1

08.30 – 09.40 hrs    Session 1: Opening session: State-of-the-art lectures

Chair: Benedicte de Winter, Belgium, Nele Brusselaers, Belgium

08.30 – 08.40 hrs               

1.1. Course Introduction and Welcome

Annemieke Smet, Antwerp, Belgium

 

08.40 – 09.10 hrs               

1.2. Current understanding of the human microbiome

Martin Blaser, Piscataway, NJ, USA

 

09.10 – 09.40 hrs               

1.3. The microbiome in early life

Maria Gloria Dominguez Bello, Piscataway, NJ, USA

 

 

09.40 – 10.10 hrs                Coffee Break

Room Gorilla 2 - 4

10.10 - 12.10 hrs     Session 2: Partners in slime - How mucins interact with the microbiota

Chair: Annemieke Smet, Belgium, Yaron Niv, Israel

10.10 – 10.35 hrs               

2.1 The past, present and future of mucin-microbe interactions

Malin Johansson, Gothenburg, Sweden

10.35 – 11.00 hrs               

2.2. Profiling mucin-degrading microbes in the human gut microbiota

Mindy Engevik, Charleston, SC, USA

11.00 – 11.25 hrs               

2.3. Akkermansia muciniphila: a friendly bacterium who cares mucus

Clara Belzer, Wageningen, The Netherlands

11.25 – 11.50 hrs               

2.4. Crosstalk between Helicobacter and mucins: a hate and love relationship

Yaron Niv, Tel Aviv, Israel

11.50– 13.00 hrs                Lunch Break

Room Gorilla 2 - 4

13.00 – 14.50 hrs Session 3: Microbiota-organ axes: a microbial outreach and networking

Chair: Sarah Lebeer, Belgium, Lukas Van Oudenhove, Belgium

13.00 – 13.25 hrs               

3.1. Gut-vaginal microbial crosstalk: implications for women’s health

Henriette Svarre Nielsen, Copenhagen, Denmark

13.25 – 13.50 hrs               

3.2. Gut microbiota as driving force in NAFLD development

Max Nieuwdorp, Amsterdam, The Netherlands

13.50 – 14.15 hrs               

3.3. Microbiota-Gut-Brain axis: mechanistic insights from rodent studies

Gerard Clarke, Cork, Ireland

 

14.15 – 14.32 hrs               

3.4. From Mice to Men: Translational and Clinical Studies on the Microbiota-Gut-Brain axis | Tandem Talk

Lukas Van Oudenhove, Leuven, Belgium

14.32 – 14.50 hrs               

3.5. From Mice to Men: Translational and Clinical Studies on the Microbiota-Gut-Brain axis | Tandem Talk

Boushra Dalile, Leuven, Belgium

 

 

14.50 – 16.05 hrs    Session 4: Microbial therapy – opportunities and challenges

Chair: Lars Engstrand, Sweden, Nele Brusselaers, Belgium

14.50 – 15.15 hrs               

4.1. Culturomics: paradigm shift in the human gut microbiome story

Lars Engstrand, Stockholm, Sweden

15.15 – 15.40 hrs               

4.2. In vitro microbiota culture as treatment for dysbiosis

Juan Du, Solna, Sweden

15.40 – 16.05 hrs               

4.3. The challenges of microbiota-based interventions

Gabriel Leventhal, Schlieren, Switzerland 

 

16.05 – 16.35 hrs                Coffee Break

Room Gorilla 2 - 4

16.35 – 17.50 hrs    Session 5: Translating the gut microbiota - ready for the clinic?

Chair: Marie Joossens, Belgium, Herbert Tilg, Austria

16.35 – 17.00 hrs               

5.1. Bridging the gap between preclinal and clinical microbial research

Pieter Van den Abbeele, Ghent, Belgium

 

17.00 – 17.25 hrs               

5.2. Translational metabolomics: where are we now?

Herbert Tilg, Innsbruck, Austria

 

17.25 – 17.50 hrs               

5.3. The gut microbiome and its role in shaping the immunotherapy outcome in cancer

Gianmarco Piccinno, Trento, Italy

 

17.50 – 18.05 hrs    Session 6: Closing

6.1. Annemieke Smet, Antwerp, Belgium

19.00 – 20.00

Welcome Reception | Details to follow

bottom of page